Gary S Jacob is Chief Executive Officer of OKYO Pharma Ltd. Currently has a direct ownership of 12,500 shares of OKYO, which is worth approximately $13,875. The most recent transaction as insider was on May 19, 2022, when has been sold 12,500 shares (American Depositary Shares) at a price of $4.0 per share, resulting in proceeds of $50,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K
0% 3M change
0% 12M change
Total Value Held $13,875

GARY S JACOB Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2022
BUY
Open market or private purchase
$50,000 $4.0 p/Share
12,500 Added 50.0%
12,500 American Depositary Sh...

Also insider at

CRDF
Cardiff Oncology, Inc. Healthcare
HEPA
Hepion Pharmaceuticals, Inc. Healthcare
VRPX
Virpax Pharmaceuticals, Inc. Healthcare
GSJ

Gary S Jacob

Chief Executive Officer
Edison, NJ

Track Institutional and Insider Activities on OKYO

Follow OKYO Pharma Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OKYO shares.

Notify only if

Insider Trading

Get notified when an Okyo Pharma LTD insider buys or sells OKYO shares.

Notify only if

News

Receive news related to OKYO Pharma Ltd

Track Activities on OKYO